ZimVie Inc. announced on January 30, 2025, the publication of a scientific study in the Journal of Biomedical Materials Research. The study, titled 'The Role of Implant Coronal Surface Properties on Early Adhesion of Streptococcus Oralis —An In Vitro Comparative Study,' supports the benefits of ZimVie’s implant surface technologies.
The research demonstrated that the dual acid-etched (DAE) coronal surface technology of ZimVie’s T3 PRO and TSX Implants may help lower the risk of peri-implant infections. This is achieved by exhibiting bacterial adhesion levels comparable to smooth machined surfaces while promoting crestal bone maintenance.
Hai Bo Wen, Research Director at ZimVie, stated that the company's Contemporary Hybrid Surface technologies have demonstrated success in mitigating concerns regarding peri-implant mucositis and peri-implantitis. This clinical validation reinforces the differentiation and quality of ZimVie's premium dental implants.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.